Menu
GeneBe

rs146519878

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_138694.4(PKHD1):c.9788T>C(p.Val3263Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,613,826 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V3263V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 10 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

9
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:5

Conservation

PhyloP100: 3.40
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064140856).
BP6
Variant 6-51747828-A-G is Benign according to our data. Variant chr6-51747828-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 167477.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=2, Benign=1}. Variant chr6-51747828-A-G is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PKHD1NM_138694.4 linkuse as main transcriptc.9788T>C p.Val3263Ala missense_variant 58/67 ENST00000371117.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PKHD1ENST00000371117.8 linkuse as main transcriptc.9788T>C p.Val3263Ala missense_variant 58/671 NM_138694.4 P2P08F94-1
PKHD1ENST00000340994.4 linkuse as main transcriptc.9788T>C p.Val3263Ala missense_variant 58/615 A2P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.00249
AC:
378
AN:
152100
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00338
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00167
AC:
420
AN:
251166
Hom.:
1
AF XY:
0.00168
AC XY:
228
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000782
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.000462
Gnomad NFE exome
AF:
0.00321
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00306
AC:
4468
AN:
1461608
Hom.:
10
Cov.:
33
AF XY:
0.00298
AC XY:
2168
AN XY:
727120
show subpopulations
Gnomad4 AFR exome
AF:
0.000658
Gnomad4 AMR exome
AF:
0.000985
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.000487
Gnomad4 NFE exome
AF:
0.00378
Gnomad4 OTH exome
AF:
0.00250
GnomAD4 genome
AF:
0.00248
AC:
378
AN:
152218
Hom.:
4
Cov.:
32
AF XY:
0.00226
AC XY:
168
AN XY:
74414
show subpopulations
Gnomad4 AFR
AF:
0.000674
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00338
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00293
Hom.:
4
Bravo
AF:
0.00290
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00173
AC:
210
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00365
EpiControl
AF:
0.00332

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 04, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 16, 2017Variant summary: The PKHD1 c.9788T>C (p.Val3263Ala) variant causes a missense change involving the alteration of a conserved nucleotide. 2/3 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 463/258028 control chromosomes (gnomAD), including 2 homozygotes, at a frequency of 0.0017944, which does not exceed the estimated maximal expected allele frequency of a pathogenic PKHD1 variant (0.0070711). Clinical diagnostic laboratories/reputable databases classified this variant as likely benign and uncertain significance. The variant of interest has been reported in multiple patients with ARPKD (Melchionda_2016, Sharp_2005) and pathologies with partially overlapping renal phenotype, including one patient with dominantly inherited isolated polycystic liver disease (Besse_2017), all without strong evidence for causality. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until more definitive clinical and functional data become available. -
Autosomal recessive polycystic kidney disease Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 23, 2020This variant is associated with the following publications: (PMID: 21228398, 15805161) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024PKHD1: BP4 -
Polycystic kidney disease Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKHD1, p.Val3263Ala variant was identified in 2 of 274 proband chromosomes (frequency: 0.007) from individuals or families with ARPKD, and was not identified in 200 control chromosomes from healthy individuals (Sharp 2005, Gunay-Aygun 2010). The variant was also identified in dbSNP (ID: rs146519878) as “With Uncertain significance allele”, Clinvitae database (classified as unclassified variant by ClinVar and Invitae), the ClinVar database (classified as uncertain significance by Emory Genetics and Invitae), RWTH AAachen University ARPKD database (classified as probably benign) and PKHD1-LOVD (2x as unknown/not classified). This variant was identified in the 1000 Genomes Project in 6 of 5000 chromosomes (frequency: 0.0012), the NHLBI GO Exome Sequencing Project in 25 of 8600 European American and in 1 of 4406 African American alleles, the Exome Aggregation Consortium database (August 8, 2016) in 210 (1 homozygous) of 121276 chromosomes (freq. 0.002) in the following populations: European in 193 of 66708 chromosomes (freq. 0.003), Latino in 7 of 11500 chromosomes (freq. 0.0006), African in 5 of 10406 chromosomes (freq. 0.0005), Finnish in 3 of 6612 chromosomes (freq. 0.0005), South Asian in 1 of 16512 chromosomes (freq. 0.00006), Other in 1 of 906 chromosomes (freq. 0.001), although this low number of observations and low frequency is not substantive enough to determine the prevalence of the variant in the general population and its relationship to disease. The p.Val3263 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 4 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict the loss of a 5’ splice site that is not at the canonical 5’ splice site. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Autosomal dominant polycystic liver disease Uncertain:1
Uncertain significance, no assertion criteria providedresearchLaboratory of Gastroenterology and Hepatology, Radboud University Medical CenterSep 01, 2021- -
PKHD1-related condition Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 09, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
Cadd
Benign
18
Dann
Uncertain
1.0
DEOGEN2
Benign
0.28
T;.
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.53
T;T
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.0064
T;T
MetaSVM
Benign
-0.29
T
MutationAssessor
Uncertain
2.6
M;M
MutationTaster
Benign
0.87
N;N
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-2.5
N;N
REVEL
Uncertain
0.34
Sift
Benign
0.18
T;T
Sift4G
Uncertain
0.014
D;D
Polyphen
0.91
P;P
Vest4
0.39
MVP
0.92
MPC
0.18
ClinPred
0.032
T
GERP RS
5.7
Varity_R
0.11
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146519878; hg19: chr6-51612626; COSMIC: COSV99049429; API